The Ensign Group, headquartered in San Juan Capistrano, California, provides skilled nursing and rehabilitative care services through 312 facilities across 13 states and employs 35,300 people. The company went public on November 12, 2007, and operates in two segments: Skilled Services and Standard Bearer.
Based on our analysis, Ensign Group has received an overvalued rating of 2 out of 5 stars primarily due to its financial ratios that exceed industry benchmarks, indicating potential concerns about its valuation.
One significant metric to consider is the Price-to-Earnings (PE) Ratio, which stands at 25.36 compared to the sector average of 14.78. A higher PE ratio suggests that investors may be paying more for each dollar of earnings, which can indicate overvaluation. Additionally, the Price-to-Book (PB) Ratio for Ensign Group is 4.14, while the sector average is 2.69. This higher PB ratio may imply that the stock is priced significantly above its book value, raising concerns about its fair market value.
Despite Ensign Group's strong performance in other areas, such as its net profit margin of 6.99 compared to a negative sector average, these ratios suggest that the stock may be less attractive from a valuation perspective. Furthermore, the Return on Equity (ROE) at 16.22, while positive, does not fully compensate for the elevated valuation metrics.
The dividend yield of 0.18 is also below the sector average of 0.25, indicating that investors receive less in dividend returns relative to the sector, which can further contribute to a perception of overvaluation.
This analysis highlights that while Ensign Group has strong profitability metrics, its elevated valuation ratios may make it less appealing to investors seeking value.
This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Health Care
Overvalued
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.